Vita Cold
Natural health product licensed in Canada
- Other names
- Cold Check, Cold Cover, Cold Relief, Cold Sinous, Coldex, Fixacold, Rinucold, Vitacold
- Licence holder
- STP Pharmaceutical Corp
- NPN or DIN-HM
- 80079166
- Status
- Active licence
- Licence date
- 25 July 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 1,000 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 500 milligramme | 1,000,000 µg |
| Sélénium Source : Citrate de sélénium | 100 microgrammes | Not calculated |
| Zinc Source : Sulfate de zinc | 15 milligramme | 30,000 µg |
| Echinacea purpurea Source : Sommité | 150 milligramme | Not calculated |
| Hydrastis canadensis Source : Racine et rhizome | 50 milligramme | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus aurantium - fruit | 50 milligramme | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus aurantium - Fruit peel | 50 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Croscarmellose de sodium, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps to maintain immune function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have a history of non-melanoma skin cancer, consult a health care practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner. If you are taking immunosuppressants, consult a health care practitioner prior to use. If you have an autoimmune disorder, consult a health care practitioner prior to use. If you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, AIDS and/or HIV infection, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have a kidney disorder. Consult a health care practitioner prior to use if you have blood pressure problems. Consumption of Goldenseal with alcohol, other medications and/or natural health products with sedative properties is not recommended. If you are taking prescription medication, consult a healthcare practitioner prior to use as citrus bioflavonoids may alter the effectiveness of these medications.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Effets indésirables connus
Rare cases of severe allergic reactions have been known to occur; use caution if you are allergic to plants of the Daisy family.
Source
Official Health Canada record, licence 80079166
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.